January 25, 2017
Via: FortunePresident Donald Trump’s executive order withdrawing the U.S. from a historic Pacific free trade agreement checked the box for one of his flagship campaign promises. But it leaves the biopharma industry in limbo over some key intellectual property issues. The […]
April 23, 2024
March 28, 2024